# Recurrence Risk Evaluation by 21-gene Detection

> **NCT03841266** · — · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 220 (actual)

## Conditions studied

- Relationship and Consistency Analysis

## Interventions

- **DIAGNOSTIC_TEST:** recurrence risk evaluation

## Key facts

- **NCT ID:** NCT03841266
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2019-01-20
- **Final completion:** 2019-02-01
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03841266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03841266, "Recurrence Risk Evaluation by 21-gene Detection". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03841266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*